1
Total investments
1
Early stage
0
Mid stage
0
Late stage
3y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board Member
Aug 2023
WIN Ventures is an investment company with women shareholders investing together in innovative companies and other outstanding
opportunities in the Nordics.
Experience · 3 entries
All (3)
Investments (1)
Board (1)
2023
Investor & Board Member
Aug 2023
WIN Ventures is an investment company with women shareholders investing together in innovative companies and other outstanding
opportunities in the Nordics.
2016
Head of Portfolio and Project Management
Sep 2016
Inven2 is the largest technology transfer office in the Nordic region.
We are responsible for:
- Commercialization of innovations from our owners
- Administration and financial follow up of clinical trials
- Administration of Research fund
Inven2’s goal is to make research benefit society and to contribute to value creation.
Inven2 is owned by the University of Oslo and Oslo University Hospital.
2003
A
Group Leader Cell-Based Antibody Selection
Jan 2003
About
Affitech A/S was formed in May 2009 by a combination of Oslo, Norway-based Affitech AS, a human antibody therapeutics research company and Pharmexai A/S, a publicly traded former vaccine research and development company, based in Denmark.
The combination starts the transformation of Affitech into a major human antibody company with research labs in Oslo, Norway and Finance, Administration, Investor Relations and Communications in Copenhagen, Denmark.